We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:IMDX
​
​
logo

Insight Molecular Diagnostics Inc. (IMDX)

Nasdaq • IMDX • US68235C2061

2.38Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 27, 2026, ORTEX estimated 10.3% of free float sold short, 3.6 days to cover, cost to borrow 5.13%. Sign up for live short interest data.

Market Cap

78m USD | # 8701 in US

Volume

237.97k shares | 848.95k USD

Shares Outstanding

32.72m

Free Float Shares

30.49% | 9.98m

DB:7OC0|
LSE:0KCC

News

IMDX key data

Insight Molecular Diagnostics Inc. (Nasdaq: IMDX) has a market capitalization of $78.05M. Last close $2.39 (as of 2026-11-12); 52-week range $2.35 to $8.51. ORTEX data as of 2026-10-27: short interest was 10.26% of free float, 3.6 days to cover and the average cost to borrow was 5.13%. Sign up for live short interest data.

  • IMDX news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.